Get started
Author

Marisa Iborra

Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients
2016 · Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU)., Marisa Iborra, et al. · Journal of Gastroenterology · 66
Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients
2016 · Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU)., Marisa Iborra, et al. · Journal of Gastroenterology · 52
PDF
P365 Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice
2017 · M. Aguas, V. Bosό, et al. · Journal of Crohn s and Colitis · 24
538 Correlation Between Adalimumab Serum Levels and Remission After the Induction Phase in Crohn's Disease Patients
2015 · Maria Chaparro, Iván Guerra, et al. · Gastroenterology · 5
P462 Efficacy of ustekinumab for the prevention of postoperative recurrence in crohn’s disease. Data from clinical practice from the eneida registry
2020 · M Mañosa Ciria, A Fernandez-Clotet, et al. · Journal of Crohn s and Colitis · 3
PDF
P0937 Role of Interleukin-8 in Predicting Long-Term Response to Vedolizumab in Ulcerative Colitis Patients
2025 · A Mínguez, P Ripoll, et al. · Journal of Crohn s and Colitis · 2
Tu1291 Infliximab Serum Levels Do Not Predict Remission After the Induction Phase in Crohn's Disease Patients
2015 · Maria Chaparro, Iván Guerra, et al. · Gastroenterology · 2
Sa2029 Impact of Adalimumab in the Prevention of Postoperative Recurrences of Crohn's Disease in High-Risk Patients
2012 · Mariam Aguas, Guillermo Bastida, et al. · Gastroenterology · 2
OP37 Effect of the HLA-DQA1*05 allele on the efficacy of ustekinumab in patients with Crohn's Disease. Multicenter study based on the ENEIDA registry of GETECCU
2024 · J Guardiola Capón, M Iborra, et al. · Journal of Crohn s and Colitis · 1
PDF
P290 Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?
2022 · R Ferreiro Iglesias, M S Porto Silva, et al. · Journal of Crohn s and Colitis · 1
PDF
Artículos más relevantes en investigación básica
2016 · M. García-Campos, M. Iborra · Enfermedad Inflamatoria Intestinal al Día · 1
Tu1292 Quantification of the Concentration of Antibodies Against Infliximab (IFX) in Human Serum Using a Pure Antibody As Calibrator
2015 · Borja Hernandez-Breijo, Maria Chaparro, et al. · Gastroenterology · 1
P172 Fecal calprotectin (FC) is a useful early predictive marker for postoperative recurrence in Crohn's disease (CD)
2012 · B. Beltrán, E. Cerrillo, et al. · Journal of Crohn s and Colitis · 1
P298 - Permanent catalase activity impairment due to minor expression of catalase protein in peripheral white mononuclear cells of patients with naive and treated Crohn's disease
2009 · M. Iborra, P. Nos, et al. · Journal of Crohn s and Colitis · 1
Training satisfaction, competency gaps and well-being in gastroenterology residency in Spain: results of a national SEPD survey
2026 · Marisa Iborra, María Dolores Martín-Arranz, et al. · BMC Gastroenterology
Trends in Incidence and Prevalence of Inflammatory Bowel Disease in Spain: A Nationwide Population-Based Study (2011�2024)
2026 · Eduard Brunet, Stephanie Coward, et al. · Revista Española de Enfermedades Digestivas
Spanish Working Group in Crohn's Disease and Ulcerative Colitis (GETECCU) position paper for the management of non-perianal fistulizing Crohn’s disease
2025 · Iago Rodríguez-Lago, Diego Casas-Deza, et al. · Gastroenterología y Hepatología (English Edition)
P-66 - Evaluación De La Interleuquina-8 Como Biomarcador Predictivo De Respuesta a Largo Plazo a Vedolizumab En Colitis Ulcerosa
2025 · Alejandro Mínguez Sabater, Irene Navarrete Perez, et al. · Gastroenterología y Hepatología
P-29 - Efectividad De Upadacitinib En La Enfermedad De Crohn: Experiencia Inicial En Vida Real Desde La Base De Datos Eneida
2025 · Marisa Iborra, Belén Botella, et al. · Gastroenterología y Hepatología
Position Paper of the Spanish Society of Digestive Pathology (SEPD) and the Spanish Association of Digestive Ultrasound (AEED) On the need to integrate digestive ultrasound into all Gastroenterology departments
2025 · Federico Argüelles-Arias, Joaquín Poza Cordón, et al. · Revista Española de Enfermedades Digestivas
Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine
2024 · Guillermo Bastida, Diego Alvarez-Sotomayor, et al. · Gastroenterología y Hepatología (English Edition)
477 Efficacy, Safety and Pharmacokinetic Data of Switching From Intravenous to Subcutaneous Infliximab in Inactive Inflammatory Bowel Disease Patients. Real-life Evidence From Eneida Registry.
2023 · Marisa Iborra, Alejandro Garrido Marín, et al. · Gastroenterology
PDF
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort
2023 · Iborra, Marisa, Ferreiro-Iglesias, Rocio, et al. · Figshare
Sa1900 BIOMARKERS RESPONSE TO ANTI-TNF TREATMENT IN CROHN'S DISEASE THROUGH THE INTESTINAL MICROBIOTA
2020 · Laura Sanchis, Sergio Manresa-Vera, et al. · Gastroenterology
Su1868 EPIGENETIC PREDICTION OF CROHN'S DISEASE RECURRENCE: SPECIFIC PLASMA MICRORNAS PROFILES IN PRE-SURGERY AND IN ESTABLISHED RECURRENCE
2020 · Inés Moret, Elena Cerrillo, et al. · Gastroenterology
Works count: 43
Citation count: 162
H-index: 4
I10-index: 3
Year
Topic
Type